Orita Yoshimasa, Gejyo Fumitake, Sakatsume Minoru, Shiigai Tatsuo, Maeda Yoshitaka, Imai Enyu, Fujii Takashi, Endoh Masayuki, Jinde Kiichiro, Haneda Masakazu, Sugimoto Toshiro, Hishida Akira, Takahashi Satoru, Hosoya Tatsuo, Yamamoto Hiroyasu, Hora Kazuhiko, Okada Yoichi, Hosaka Shigetoshi, Oguchi Tomomasa, Kanno Yutaka, Nishio Yasuhide, Yano Shintaro, Aikawa Kazuo, Yasui Kiyoshi
College of Nutrition Koshien University, Hyogo.
Nihon Jinzo Gakkai Shi. 2005;47(7):804-12.
Inulin clearance (Cin) is widely believed to be the gold standard of the glomerular filtration rate (GFR). However, in Japan, Cin has not been officially recognized by the Ministry of Health, Labour and Welfare of Japan for clinical use. Creatinine clearance (Ccr) has been used to estimate the renal function of patients, but there have been many studies in which Ccr estimates were GFR falsely high because the metabolism and tubular excretion of creatinine widely varied according to the pathophysiological state of the patient. In the present study, we determined Cin and Ccr simultaneously in 116 adult patients with renal diseases and diabetic mellitus. The clearance study was performed by the modified Wesson's method. The inulin preparation was FFI-1010 (Fuji Yakuhin Co. Ltd.). Inulin in serum and urine was determined by the newly devised enzymatic assay (Toyobo Co. Ltd.), which is specific for inulin. The mean Cin was 35.0 +/- 14.4 ml/min/1.73 m2. The mean Ccr(the enzyme assay) was 63.6 +/- 24.1 ml/min/1.73 m2 and that of the kinetic Jaffe assay was 55.3 +/- 19.3 ml/min/1.73 m2. Mean Ccr/Cin was 1.93 +/- 0.73, 1.69 +/- 0.62, respectively. This ratio was significantly different(p < 0.05) in the degree of reduction of Cin, with values of 2.07 +/- 0.82 (Cin < 40 ml/min/1.73 m2) and 1.64 +/- 0.32(40 < Cin < 80 ml/min/1.73 m2), respectively. Only 8 patients were classified into the same degree of reduced renal function (the Guideline of Japanese Society of Nephrology). The findings of this study suggest that the GFR determined by Ccr could misjudge the renal function of patient and delay the administration of proper treatment of the patient. Introduction of Cin into the clinical field is necessary to avoid this delay.
菊粉清除率(Cin)被广泛认为是肾小球滤过率(GFR)的金标准。然而,在日本,菊粉清除率尚未得到日本厚生劳动省的官方认可用于临床。肌酐清除率(Ccr)一直被用于评估患者的肾功能,但有许多研究表明,由于肌酐的代谢和肾小管排泄会因患者的病理生理状态而有很大差异,Ccr的估算值往往会使GFR偏高。在本研究中,我们同时测定了116例成年肾病和糖尿病患者的菊粉清除率和肌酐清除率。清除率研究采用改良的韦森法进行。菊粉制剂为FFI - 1010(富士药品株式会社)。血清和尿液中的菊粉采用新设计的酶法测定(东洋纺株式会社),该方法对菊粉具有特异性。平均菊粉清除率为35.0±14.4 ml/min/1.73 m²。平均肌酐清除率(酶法)为63.6±24.1 ml/min/1.73 m²,动力学碱性苦味酸法测定的平均肌酐清除率为55.3±19.3 ml/min/1.73 m²。平均Ccr/Cin分别为1.93±0.73、1.69±0.62。该比值在菊粉清除率降低程度上有显著差异(p < 0.05),当菊粉清除率<40 ml/min/1.73 m²时为2.07±0.82,当40 <菊粉清除率<80 ml/min/1.73 m²时为1.64±0.32。只有8例患者被归类为相同程度的肾功能减退(日本肾脏病学会指南)。本研究结果表明,通过肌酐清除率测定的肾小球滤过率可能会误判患者的肾功能,并延误对患者的适当治疗。将菊粉清除率引入临床领域对于避免这种延误是必要的。